Aufrufe: 5
Franklinton, North Carolina--(Newsfile Corp. - May 18, 2026) - Microbiome Labs™, a leader in microbiome-based solutions, announces the official launch of EpicDefense™ on Amazon, expanding consumer access to its latest microbiome-focused immune-support formula.
EpicDefense is formulated to support the body's natural defenses and promote respiratory comfort through a direct, science-first approach*. With this launch, Microbiome Labs is delivering a professional-grade immunobiotic formula that shifts the focus from reactive supplementation to proactive, gut-powered resilience.
The formula combines clinically studied strains selected to support respiratory health and immune balance, including:
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11973/297372_microbiome1.jpg
"For too long, immune support has focused on short-term reactions rather than building resilient systems," says Alicia Galvin, MEd, RD, LD, IFNCP, head of scientific affairs at Microbiome Labs. "EpicDefense reflects a shift toward proactive, gut-powered defense grounded in clinical science and made accessible without compromising rigor. This launch represents our commitment to translating validated microbiome research into real-world solutions."
EpicDefense is non-GMO, soy-free and dairy-free, meeting the rigorous standards healthcare practitioners and microbiome experts expect. To learn more about the company's mission to pioneer health, visit microbiomelabs.com.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
###
About Microbiome Labs
Microbiome Labs, part of Novonesis Human Health Biosolutions, provides innovative, research-based solutions that support the body's microbial ecosystem. With a focus on clinical application and practitioner partnerships, Microbiome Labs delivers evidence-informed products designed to support overall wellness. Learn more at microbiomelabs.com.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297372
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
